![]() | |
Names | |
---|---|
Preferred IUPAC name
[3-(4-Chlorophenyl)[1,3]thiazolo[3,2-a] [1,3]benzimidazol-2-yl]acetic acid | |
Identifiers | |
3D model (
JSmol)
|
|
ChEMBL | |
ChemSpider | |
KEGG | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C17H11ClN2O2S | |
Molar mass | 342.80 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Tilomisole (WY-18,251) is an experimental drug which acts as an immunomodulator and has been studied for the treatment of some forms of cancer. [1] [2]
It can also be seen to contain the arylacetic acid moiety that is endemic to many NSAIDs, e.g. ibufenac.[ citation needed]
![]() | |
Names | |
---|---|
Preferred IUPAC name
[3-(4-Chlorophenyl)[1,3]thiazolo[3,2-a] [1,3]benzimidazol-2-yl]acetic acid | |
Identifiers | |
3D model (
JSmol)
|
|
ChEMBL | |
ChemSpider | |
KEGG | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C17H11ClN2O2S | |
Molar mass | 342.80 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Tilomisole (WY-18,251) is an experimental drug which acts as an immunomodulator and has been studied for the treatment of some forms of cancer. [1] [2]
It can also be seen to contain the arylacetic acid moiety that is endemic to many NSAIDs, e.g. ibufenac.[ citation needed]